Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.

Arthritis and rheumatism | Oct 9, 2008

http://www.ncbi.nlm.nih.gov/pubmed/18821706

OBJECTIVE: To determine whether Smurf2, an E3 ubiquitin ligase known to inhibit transforming growth factor beta (TGFbeta) signaling, is expressed in human osteoarthritic (OA) cartilage and can initiate OA in mice. METHODS: Human OA cartilage was obtained from patients undergoing knee arthroplasty. Samples were graded histologically using the Mankin scale and were examined immunohistochemically for Smurf2 expression. A transgene driven by the collagen 2alpha1 promoter was used to overexpress Smurf2 in mice. Smurf2 overexpression in mouse sternal chondrocytes was confirmed by reverse transcription-polymerase chain reaction and Western blotting. Changes in articular cartilage area, chondrocyte number, and chondrocyte diameter were assessed histomorphometrically using OsteoMeasure software. Alterations in type X collagen and matrix metalloproteinase 13 (MMP-13) in articular chondrocytes were examined by in situ hybridization and immunohistochemistry, respectively. Joint bone phenotypes were evaluated by microfocal computed tomography. The effects of Smurf2 overexpression on TGFbeta signaling were examined using a luciferase-based reporter and immunoprecipitation/Western blotting. RESULTS: Human OA cartilage strongly expressed Smurf2 as compared with nonarthritic human cartilage. By 8 months of age, Smurf2-transgenic mice exhibited decreased articular cartilage area, fibrillation, clefting, eburnation, subchondral sclerosis, and osteophytes. Increased expression of type X collagen and MMP-13 were also detected in articular cartilage from transgenic mice. Transgenic sternal chondrocytes showed reduced TGFbeta signaling as well as decreased expression and increased ubiquitination of pSmad3. CONCLUSION: Smurf2 is up-regulated during OA in humans, and Smurf2-transgenic mice spontaneously develop an OA-like phenotype that correlates with decreased TGFbeta signaling and increased pSmad3 degradation. Overall, these results suggest a role of Smurf2 in the pathogenesis of OA.

Pubmed ID: 18821706 RIS Download

Mesh terms: Animals | Cells, Cultured | Chondrocytes | Disease Models, Animal | Humans | Mice | Mice, Transgenic | Osteoarthritis, Knee | Smad3 Protein | Ubiquitin-Protein Ligases | Up-Regulation

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIAMS NIH HHS, Id: 5P50-AR-054041-03
  • Agency: NIAMS NIH HHS, Id: K02 AR052411
  • Agency: NIAMS NIH HHS, Id: K02 AR052411-01A2
  • Agency: NIAMS NIH HHS, Id: K02 AR052411-02
  • Agency: NIA NIH HHS, Id: P01-AG-018254
  • Agency: NIAMS NIH HHS, Id: R01 AR051189
  • Agency: NIAMS NIH HHS, Id: R01 AR051189-02
  • Agency: NIAMS NIH HHS, Id: R01 AR051189-03
  • Agency: NIAMS NIH HHS, Id: R01 AR051189-04
  • Agency: NIAMS NIH HHS, Id: R01 AR054465
  • Agency: NIAMS NIH HHS, Id: R01 AR054465-01
  • Agency: NIAMS NIH HHS, Id: R01 AR054465-02
  • Agency: NIAMS NIH HHS, Id: R01-AR-045700
  • Agency: NIAMS NIH HHS, Id: R01-AR-048681
  • Agency: NIAMS NIH HHS, Id: R01-AR-38945

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.